A future beyond
Type 1 Diabetes

We champion bold research and visionary scientists to get closer to a world where Type 1 Diabetes is no longer a daily burden.


Our beneficiaries


Progress today cure tomorrow


At the Bukhman Foundation, one of our core missions is to find a cure for people with Type 1 Diabetes (T1D). We believe that bold ideas and visionary leadership can get us there. By partnering with researchers who push boundaries and challenge conventional thinking, we aim to build a future where T1D no longer limits how people live, dream, and thrive.


Our approach to funding medical research is grounded in partnership, trust, and long-term ambition. We support cutting-edge science, promote open research, and encourage collaboration between leading experts and institutions across the globe.


Our pledge

£100m to transform lives


The Bukhman Foundation is pledging the UK’s largest philanthropic commitment to funding groundbreaking research into treatments and cures for Type 1 Diabetes.



What we’re supporting

The Bukhman Centre for Research Excellence in Type 1 Diabetes

Catalysing breakthroughs at Oxford to cure Type 1 Diabetes.

2025Status: Active

Project highlights

See all
Type 1 Diabetes 31 October 2025

Driving Type 1 Diabetes Innovation Forward

Bukhman Foundation commits $12M to T1D Fund, driving research, innovation, and global collaboration.

Type 1 DiabetesBreakthrough T1D
Type 1 Diabetes 25 September 2025

The Bukhman Centre for Research Excellence in Type 1 Diabetes

A new partnership with University of Oxford to accelerate research, foster collaboration, and bring us closer to a cure for Type 1 Diabetes.

Type 1 DiabetesUniversity of Oxford
Type 1 Diabetes 16 May 2025

Bukhman Foundation announces £100 milion commitment towards Type 1 Diabetes

A 10 year commitment to accelerate groundbreaking research and bring new treatments and a cure for Type 1 Diabetes.

Type 1 Diabetes

Who we partner with


We partner with leading researchers and institutions globally, supporting innovative, expert-led research that pushes scientific boundaries and aims for transformational impact. Our partners include University of Oxford, Cambridge University, Harvard University, Breakthrough T1D, T1D Fund and Diabetes UK.